Achaogen, Inc. has announced that Blake Wise, currently the company’s president and chief operating officer, will become chief executive officer effective January 1, 2018. He will also be joining Achaogen’s board of directors.   Kenneth Hillan, the company’s current chief executive officer, will move on to the newly created role of president of R&D, and president of Achaogen overall. Dr. Hillan will remain on the company’s board of directors.   “Achaogen is preparing for appr...